Literature DB >> 19342479

Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.

Cathy Cecilia Srokowski1, Joumana Masri, Nadine Hövelmeyer, Anna Katharina Krembel, Christine Tertilt, Dennis Strand, Karsten Mahnke, Ramin Massoumi, Ari Waisman, Hansjörg Schild.   

Abstract

Deubiquitination of NF-kappaB members by CYLD is crucial in controlling the magnitude and nature of cell activation. The role of the naturally occurring CYLD splice variant in dendritic cell (DC) function was analyzed using CYLD(ex7/8) mice, which lack the full-length CYLD (flCYLD) transcript and overexpress the short splice variant (sCYLD). Bone marrow-derived DCs from CYLD(ex7/8) mice display a hyperactive phenotype in vitro and in vivo and have a defect in establishing tolerance with the use of DEC-205-mediated antigen targeting to resting DCs. The combination of sCYLD overexpression and lack of flCYLD in CYLD(ex7/8) DCs leads to enhanced NF-kappaB activity accompanied by an increased nuclear translocation of the IkappaB molecule Bcl-3, along with nuclear p50 and p65. This suggests that, in contrast to flCYLD, sCYLD is a positive regulator of NF-kappaB activity, and its overexpression induces a hyperactive phenotype in DCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342479     DOI: 10.1182/blood-2008-08-175489

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.

Authors:  Shuai Liu; Jiaju Lv; Liping Han; Tomonaga Ichikawa; Wenjuan Wang; Siying Li; Xing Li Wang; Dongqi Tang; Taixing Cui
Journal:  Biochem Biophys Res Commun       Date:  2012-03-01       Impact factor: 3.575

2.  Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Authors:  Lara Manganaro; Lars Pache; Tobias Herrmann; John Marlett; Young Hwang; Jeffrey Murry; Lisa Miorin; Adrian T Ting; Renate König; Adolfo García-Sastre; Frederic D Bushman; Sumit K Chanda; John A T Young; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.

Authors:  Jens Staal; Yasmine Driege; Tine Bekaert; Annelies Demeyer; David Muyllaert; Petra Van Damme; Kris Gevaert; Rudi Beyaert
Journal:  EMBO J       Date:  2011-03-29       Impact factor: 11.598

Review 4.  Regulation of NF-κB by deubiquitinases.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 5.  CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.

Authors:  Marie Lork; Kelly Verhelst; Rudi Beyaert
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

6.  The deubiquitinating enzyme CYLD regulates the differentiation and maturation of thymic medullary epithelial cells.

Authors:  Sonja Reissig; Nadine Hövelmeyer; Yilang Tang; Debra Weih; Alexey Nikolaev; Marc Riemann; Falk Weih; Ari Waisman
Journal:  Immunol Cell Biol       Date:  2015-01-20       Impact factor: 5.126

7.  The deubiquitinase CYLD controls protective immunity against helminth infection by regulation of Treg cell plasticity.

Authors:  Jee H Lee; Le Zou; Runqing Yang; Jihye Han; Qingqing Wan; Xian Zhang; Sarah El Baghdady; Andrea Roman; Chris Elly; Hyung-Seung Jin; Yoon Park; Michael Croft; Yun-Cai Liu
Journal:  J Allergy Clin Immunol       Date:  2020-12-10       Impact factor: 14.290

8.  Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.

Authors:  Melania Tesio; Yilang Tang; Katja Müdder; Massimo Saini; Lisa von Paleske; Elizabeth Macintyre; Manolis Pasparakis; Ari Waisman; Andreas Trumpp
Journal:  J Exp Med       Date:  2015-03-30       Impact factor: 14.307

9.  Transcriptome innovations in primates revealed by single-molecule long-read sequencing.

Authors:  Luis Ferrández-Peral; Xiaoyu Zhan; Tomàs Marquès-Bonet; David Juan; Guojie Zhang; Marina Alvarez-Estape; Cristina Chiva; Paula Esteller-Cucala; Raquel García-Pérez; Eva Julià; Esther Lizano; Òscar Fornas; Eduard Sabidó; Qiye Li
Journal:  Genome Res       Date:  2022-07-15       Impact factor: 9.438

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.